Enhancement of antioxidant and anti-inflammatory activities of flavonoid primuletin in DSS induced colitis in C57BL/6 mice

Manish Kumar Gupta; Khairunnisa Kalathil; B Rajinikanth

doi:10.53730/ijhs.v6nS4.10159

Authors

Manish Kumar Gupta Department of Pharmaceutics, School of Pharmaceutical Sciences, Jaipur National University, Jaipur, Rajasthan 302025
Khairunnisa Kalathil
babysameer@gmail.com
Research scholar, School of Pharmaceutical Sciences, Jaipur National University, Jaipur. Rajasthan 302025
B Rajinikanth Department of Pharmacology, Grace College of Pharmacy, Palakkad, Kerala-678004

Keywords:

inflammatory bowel disease, primuletin, DSS induced IBD, ulcerative colitis, flavonoids, antioxidant, anti-inflammatory

Abstract

Background: Inflammatory Bowel Disease is a syndrome comprising of Ulcerative colitis and Crohn’s disease characterized by rectal bleeding, abdominal pain, diarrhoea, progressive weight loss and rarely infections. There are lot of drugs like corticosteroids, immunosuppressants, antibiotics to treat the disease, yet no effective treatment for the disease is available apart from treating symptomatically. Flavonoids especially Primuletin was selected as test drug to prove its anti-ulcerative colitis activity and to establish it as an effective drug for treating IBD. Materials and methods: The in-vitro activity of Primuletin was investigated against RAW 246.7 cell lines in DMEM medium. The in-vitro cytotoxicity of the drug was estimated using MTT assay and the in-vitro estimation of inflammatory markers (TNFα, IL-6) was performed using indirect Elisa. Acute oral toxicity studies were performed to determine the toxicity of Primuletin in swiss albino mice. In-vivo anti-ulcerative colitis activity of Primuletin was investigated in DSS induced IBD in C57BL/6 and the results were compared with the standard drug. Results: Primuletin treatment significantly lowered the inflammatory markers in-vitro. In DSS Primuletin treatment significantly prevented drastic variations in the body weight of mice.

Downloads

Download data is not yet available.

References

Andrews, J. M., Travis, S. P., Gibson, P. R., & Gasche, C. (2009). Systematic review: does concurrent therapy with 5-ASA and immunomodulators in inflammatory bowel disease improve outcomes?. Alimentary pharmacology & therapeutics, 29(5), 459–469.

Balmus, I. M., Ciobica, A., Trifan, A., & Stanciu, C. (2016). The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: Clinical aspects and animal models. Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 22(1), 3–17.

Baumgart, D. C., & Sandborn, W. J. (2007). Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet (London, England), 369(9573), 1641–1657.

Bradley, P. P., Christensen, R. D., & Rothstein, G. (1982). Cellular and extracellular myeloperoxidase in pyogenic inflammation. Blood, 60(3), 618–622.

Castaneda, F. E., Walia, B., Vijay-Kumar, M., Patel, N. R., Roser, S., Kolachala, V. L., Rojas, M., Wang, L., Oprea, G., Garg, P., Gewirtz, A. T., Roman, J., Merlin, D., & Sitaraman, S. V. (2005). Targeted deletion of metalloproteinase attenuates experimental colitis in mice: central role of epithelial-derived MMP. Gastroenterology, 129(6), 1991–2008.

Damayanti, I. A. M., Indrayoni, P., Antari, N. W. S., & Padmiswari, A. A. I. M. (2021). Effectiveness of Averrhoa bilimbi leaf extract on spermatogenic cells of mice (Mus Musculus L.) hyperglycemia. International Journal of Health & Medical Sciences, 4(2), 273-279. https://doi.org/10.21744/ijhms.v4n2.1747

Elson, C. O., Sartor, R. B., Tennyson, G. S., & Riddell, R. H. (1995). Experimental models of inflammatory bowel disease. Gastroenterology, 109(4), 1344–1367.

Funakoshi, K., Sugimura, K., Anezaki, K., Bannai, H., Ishizuka, K., & Asakura, H. (1998). Spectrum of cytokine gene expression in intestinal mucosal lesions of Crohn's disease and ulcerative colitis. Digestion, 59(1), 73–78.

Jadert, C., Phillipson, M., Holm, L., Lundberg, J. O., & Borniquel, S. (2013). Preventive and therapeutic effects of nitrite supplementation in experimental inflammatory bowel disease. Redox biology, 2, 73–81.

Johansson, M. E., Gustafsson, J. K., Holmén-Larsson, J., Jabbar, K. S., Xia, L., Xu, H., Ghishan, F. K., Carvalho, F. A., Gewirtz, A. T., Sjövall, H., & Hansson, G. C. (2014). Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis. Gut, 63(2), 281–291.

Kakkar, P., Das, B., & Viswanathan, P. N. (1984). A modified spectrophotometric assay of superoxide dismutase. Indian journal of biochemistry & biophysics, 21(2), 130–132.

Karak, P. (2019). Biological activities of flavonoids: an overview. International Journal of Pharmaceutical Sciences and Researches, 10(4), 1567-1574.

Kumar, S., & Pandey, A. K. (2013). Chemistry and biological activities of flavonoids: an overview. The Scientific World Journal, 2013, 162750.

Lowry, O. H., Rosebrough, N. J., Farr, A. L., & Randall, R. J. (1951). Protein measurement with the Folin phenol reagent. The Journal of biological chemistry, 193(1), 265–275.

Mahendrakumar, M., Seeni, S., & Perinbam, K. (2018). Hypericin, an Anthraquinone Derivative of Hypericum hookerianum Wight and Arn. (Hypericaceae) of Palni Hills, South India, Exhibits Anti Inflammatory Property in Lipopolysaccharide – Stimulated RAW 264.7 Macrophages. Pharmacognosy Magazine, 14(56), 378-382.

Moron, M. S., Depierre, J. W., & Mannervik, B. (1979). Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et biophysica acta, 582(1), 67–78.

Muniandy, K., Gothai, S., Badran, K., Suresh Kumar, S., Esa, N. M., & Arulselvan, P. (2018). Suppression of Proinflammatory Cytokines and Mediators in LPS-Induced RAW 264.7 Macrophages by Stem Extract of Alternanthera sessilis via the Inhibition of the NF-κB Pathway. Journal of immunology research, 2018, 3430684.

Ng, S. C., & Kamm, M. A. (2009). Therapeutic strategies for the management of ulcerative colitis. Inflammatory bowel diseases, 15(6), 935–950.

OECD Guideline for Testing of Chemicals, Acute oral toxicity, Acute-toxic class method 423.adopted 23.03.1996, June-2001.

Ohkawa, H., Ohishi, N., & Yagi, K. (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical biochemistry, 95(2), 351–358.

Pandurangan, A. K., Mohebali, N., Norhaizan, M. E., & Looi, C. Y. (2015). Gallic acid attenuates dextran sulfate sodium-induced experimental colitis in BALB/c mice. Drug design, development and therapy, 9, 3923–3934.

Seyedian, S. S., Nokhostin, F., & Malamir, M. D. (2019). A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. Journal of medicine and life, 12(2), 113–122.

Sinha A. K. (1972). Colorimetric assay of catalase. Analytical biochemistry, 47(2), 389–394.

Somani, S. J., Badgujar, L. B., Sutariya, B. K., & Saraf, M. N. (2014). Protective effect of Dillenia indica L. on acetic acid induced colitis in mice. Indian journal of experimental biology, 52(9), 876–881.

Stephen, B. H., Burton, I. K., Paul, R., Mark, A. P., & Ronald, A. (2004). Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, or placebo: A 2-year trial. World journal of gastroenterology, 127(3), 723-729.

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864

Tremaine W. J. (2011). Diagnosis and treatment of indeterminate colitis. Gastroenterology & hepatology, 7(12), 826–828.

Zhang, H., Huang, H., Zhao, X., Lv, Q., Sun, C., Li, X., & Chen, K. (2015). Effects of flavonoids-rich Chinese bayberry (Myrica rubra Sieb. et Zucc.) pulp extracts on glucose consumption in human HepG2 cells. Journal of Functional Foods,14, 144-153.